[1]
2022. Immunological Indicators in the Evaluation of the Effectiveness of Antioxidant Therapy for GEPAVID in Chronic Heavy Metal Poisoning in the Experiment. Central Asian Journal of Medical and Natural Science. 3, 2 (Mar. 2022), 197–206. DOI:https://doi.org/10.51699/cajmns.v3i2.650.